Refametinib (R enantiomer)

Overview

Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC 50 of 2.0-15 nM.

Application

Products | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MEK

Product Information

• Catalog No.: HY-10216
• CAS No.: 923032-38-6
• Molecular Formula: C19H20F3IN2O5S
• Molecular Weight: 572.34
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source